The real role of pseudokinase: linking diabetes to cancers

Area of Science:

• Oncology
• Metabolic Diseases
• Molecular Biology

Background:

• Diabetes mellitus is a risk factor for various cancers.
• Pseudokinase TRIB3 (TRIB3) and selective autophagy receptor SQSTM1 are implicated in cellular processes.
• The specific molecular mechanisms linking TRIB3 to cancer development in diabetic individuals are not fully understood.

Purpose of the Study:

• To investigate the role of pseudokinase TRIB3 in the development of diabetes-related cancers.
• To explore the interaction between TRIB3 and SQSTM1 in cancer pathogenesis.
• To evaluate the therapeutic potential of targeting the TRIB3-SQSTM1 interaction.

Main Methods:

• Utilized molecular biology techniques to study TRIB3 and SQSTM1 interactions.
• Developed and employed an alpha-helix peptide to disrupt the TRIB3-SQSTM1 complex.
• Assessed antitumor efficacy in both normal and diabetic mouse models.

Main Results:

• Identified a critical role for pseudokinase TRIB3 in diabetes-related cancer development.
• Demonstrated that TRIB3 interacts with the selective autophagy receptor SQSTM1.
• Showed that interrupting the TRIB3-SQSTM1 interaction with a peptide resulted in significant antitumor effects in vivo.
• Observed efficacy in both normal and diabetic mouse models, suggesting broad applicability.

Conclusions:

• The TRIB3-SQSTM1 interaction is a key driver in diabetes-related cancers.
• Targeting this specific molecular interaction with peptide inhibitors presents a promising therapeutic strategy.
• This approach offers a potential new avenue for treating cancers in patients with diabetes.